2020 Biotechnology Companies: Capabilities, Goals and Strategies

March 2020 | - | ID: 26F854653925EN
Venture Planning Group

Abstracts

In the dynamic and fragmented Biotechnology industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

Our collection of strategic assessments of leading Biotechnology companies provides significant competitor information, analysis and insight critical to the development and implementation of effective business, marketing and R&D programs. The assessments include latest organizational and management developments, acquisitions and divestitures, marketing tactics, financial results, strengths and weaknesses, and strategic directions.

• Alexion
• Alnylam
• Biomarin
• Exelixis
• Incyte
• Intercept Pharma
• Ionis Pharma
• Jazz Pharma
• Novo Nordisk
• Regeneron
• Seattle Genetics
• United Therapeutics
• Vertex Pharma

These reports will complement your internal competitor information gathering efforts with objective strategic analysis, data interpretation and insight.

The reports will also assist current competitors and potential market entrants in evaluating prospective acquisitions and joint venture candidates.